Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | |||
cerebral_blood_volume_index [2025/07/10 20:32] – [Cerebral blood volume index] administrador | cerebral_blood_volume_index [2025/07/10 20:41] (current) – administrador | ||
---|---|---|---|
Line 50: | Line 50: | ||
CBVI is usually obtained using software that processes dynamic contrast-enhanced imaging, integrating time–concentration curves and using deconvolution algorithms to isolate the blood volume component. | CBVI is usually obtained using software that processes dynamic contrast-enhanced imaging, integrating time–concentration curves and using deconvolution algorithms to isolate the blood volume component. | ||
---- | ---- | ||
- | In a [[retrospective cohort study]] | ||
- | Asimos et al. | ||
- | from Atrium Health, Charlotte (Emergency Medicine, Neurosciences Institute, Quality Analytics, Radiology, Neurosurgery, | ||
- | published in the [[Interventional Neuroradiology Journal]] | ||
- | to assess whether [[hypoperfusion]] intensity ratio (HIR) and [[cerebral blood volume index]] (CBVI) measured via [[CT perfusion]] at referring non-thrombectomy centers predict favorable 90‑day outcomes post-transfer for [[thrombectomy]] in [[anterior circulation]] [[large vessel occlusion]] (ACLVO). | ||
- | CBVI—as a continuous measure and specifically > | ||
- | ((Asimos AW, Yang H, Strong D, Teli KJ, Clemente JD, DeFilipp G, Bernard J, Stetler W, Parish JM, Hines A, Rhoten JB, Karamchandani RR. Association of [[hypoperfusion intensity ratio]] and [[cerebral blood volume Index]] with good [[outcome]] in patients transferred for [[thrombectomy]]. Interv Neuroradiol. 2025 Jul 10: | ||
- | ==== Critical Review ==== | ||
- | |||
- | Strengths | ||
- | |||
- | Excellent [[sample size]] (n = 497), | ||
- | |||
- | Rigorous adjustment for confounders in multivariable models enhances validity. | ||
- | |||
- | Weaknesses | ||
- | |||
- | Retrospective and single-center design at a large referral system may limit external [[generalizability]]. | ||
- | |||
- | No direct comparisons to other perfusion metrics like Tmax or ischemic core volumes—makes it difficult to situate CBVI within broader CTP prognostication tools. | ||
- | |||
- | HIR binary thresholds (0.4–0.6) may lack granularity; | ||
- | |||
- | Unclear reproducibility or inter-observer reliability of CBVI quantification across centers or software versions. | ||
- | |||
- | Statistical note | ||
- | |||
- | Adjusted OR of 1.73 for CBVI > 0.7 is clinically meaningful, but [[confidence interval]] (1.13–2.65) suggests moderate precision. | ||
- | |||
- | ==== Final Verdict ==== | ||
- | |||
- | Rating: 6.5 / 10 | ||
- | |||
- | Takeaway for practitioners: | ||
- | |||
- | Bottom line: CBVI appears promising as a simple, transportable predictor of favorable outcome in ACLVO, but further multi‑center, | ||
- | |||
- | |||
- | |||
- | Categories: Retrospective Studies, Stroke Imaging, Thrombectomy Outcomes | ||
- | |||
- | Tags: CT perfusion, CBVI, HIR, collateral perfusion, stroke prognostication, |